Literature DB >> 19608769

Prevention and treatment of medical and neurological complications in patients with aneurysmal subarachnoid haemorrhage.

Gabriel J E Rinkel1, Catharine J M Klijn.   

Abstract

Treatment of patients with aneurysmal subarachnoid haemorrhage not only involves securing the aneurysm by endovascular coiling or surgical clipping but also prevention and treatment of the medical and neurological complications of the bleed. These acutely ill patients should be looked after in specialised centres by a multidisciplinary team that is available 24 h a day, 7 days a week. No medical intervention is known to improve outcome by reducing the risk of rebleeding but oral nimodipine should be standard care to prevent delayed cerebral ischaemia. For patients who develop delayed ischaemia, there is no evidence that hypervolaemia, haemodilution, hypertension, balloon angioplasty or intra-arterial vasodilating agents improve outcome. Lumbar puncture is a safe and reasonably effective way of treating those forms of acute hydrocephalus that are not caused by intraventricular obstruction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19608769     DOI: 10.1136/jnnp.2009.182444

Source DB:  PubMed          Journal:  Pract Neurol        ISSN: 1474-7758


  4 in total

1.  Incidence of and factors associated with manipulation of nimodipine dosage in patients with aneurysmal subarachnoid hemorrhage.

Authors:  Meghan MacKenzie; Sean K Gorman; Steve Doucette; Robert Green
Journal:  Can J Hosp Pharm       Date:  2014-09

Review 2.  Seizures and anticonvulsants after aneurysmal subarachnoid hemorrhage.

Authors:  Giuseppe Lanzino; Pietro Ivo D'Urso; Jose Suarez
Journal:  Neurocrit Care       Date:  2011-09       Impact factor: 3.210

3.  Cerebral Perfusion Pressure and Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage.

Authors:  Khalil M Yousef; Jeffrey R Balzer; Catherine M Bender; Leslie A Hoffman; Samuel M Poloyac; Feifei Ye; Paula R Sherwood
Journal:  Am J Crit Care       Date:  2015-07       Impact factor: 2.228

4.  Current proceedings of childhood stroke.

Authors:  Hueng-Chuen Fan; Chih-Fen Hu; Chun-Jung Juan; Shyi-Jou Chen
Journal:  Stroke Res Treat       Date:  2011-02-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.